Nomura Holdings
ABUS icon

Nomura Holdings’s Arbutus Biopharma ABUS Stock Holding History

Nomura Holdings’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.86M Buy
+1,637,081
New +$7.19M 0.01% 622
2026
Q1 		– Sell
-98,100
Closed -$472K – 1664
2025
Q4 		$472K Sell
98,100
-1,900
-2% -$8.54K ﹤0.01% 1544
2025
Q3 		$454K Buy
100,000
+3,720
+4% +$13.7K ﹤0.01% 1624
2025
Q2 		$298K Buy
+96,280
New +$320K ﹤0.01% 1242
2015
Q1 		– Sell
-10,268
Closed -$155K – 1699
2014
Q4 		$155K Sell
10,268
-14,366
-58% -$248K ﹤0.01% 2100
2014
Q3 		$501K Sell
24,634
-34,932
-59% -$570K ﹤0.01% 1818
2014
Q2 		$777K Buy
+59,566
New +$845K ﹤0.01% 1556

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nomura Holdings's ABUS Position: Q2 2026 in Review

Nomura Holdings opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 1,637,081 shares worth $7.86M. The stake represents 0.01% of the portfolio and ranks #622 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in ABUS as recently as Q4 2025.

Nomura Holdings first reported a position in ABUS in Q2 2014 and has held it in 7 quarters since. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Nomura Holdings held 1,637,081 shares of Arbutus Biopharma worth $7.86M as of Q2 2026.
  • Arbutus Biopharma was a new Nomura Holdings position in Q2 2026.
  • Arbutus Biopharma made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #622 holding.
  • Nomura Holdings first reported a position in Arbutus Biopharma in Q2 2014 and has held it in 7 quarters since.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.